{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:17:47Z","timestamp":1790626667762,"version":"4.1.0"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T00:00:00Z","timestamp":1531094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The Aspergillus terreus species complex is found in a wide variety of habitats, and the spectrum of diseases caused covers allergic bronchopulmonary aspergillosis, Aspergillus bronchitis and\/or tracheobronchitis, and invasive and disseminated aspergillosis. Invasive infections are a significant cause of morbidity and mortality mainly in patients with hematological malignancy. The section Terrei covers a total of 16 accepted species of which most are amphotericin B resistant. Triazoles are the preferred agents for treatment and prevention of invasive aspergillosis. Poor prognosis in patients with invasive A. terreus infections seems to be independent of anti-Aspergillus azole-based treatment.<\/jats:p>","DOI":"10.3390\/jof4030083","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T11:18:53Z","timestamp":1531135133000},"page":"83","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Infections Due to Aspergillus terreus Species Complex"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-7785","authenticated-orcid":false,"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"first","affiliation":[{"name":"Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Sch\u00f6pfstra\u00dfe 41, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/520297","article-title":"Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature","volume":"26","author":"Iwen","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3114\/sim.2011.69.04","article-title":"New species in Aspergillus section Terrei","volume":"69","author":"Samson","year":"2011","journal-title":"Stud. Mycol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1128\/JCM.00917-07","article-title":"Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: Evidence of great genetic diversity","volume":"45","author":"Grif","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.01280-07","article-title":"Potential basis for amphotericin B resistance in Aspergillus terreus","volume":"52","author":"Blum","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijantimicag.2014.07.002","article-title":"Treatment of Aspergillus terreus infections: A clinical problem not yet solved","volume":"44","author":"Pastor","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Griff","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/viru.2.3.15799","article-title":"Aspergillus terreus accessory conidia are multinucleated, hyperpolarizing structures that display differential dectin staining and can induce heightened inflammatory responses in a pulmonary model of aspergillosis","volume":"2","author":"Deak","year":"2011","journal-title":"Virulence"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"776.e1","DOI":"10.1016\/j.cmi.2017.04.012","article-title":"A prospective international Aspergillus terreus survey: An EFISG, ISHAM and ECMM joint study","volume":"23","author":"Risslegger","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cmi.2015.10.021","article-title":"Geographically predominant genotypes of Aspergillus terreus species complex in Austria: A microsatellite typing study","volume":"22","author":"Lackner","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/jac\/dku241","article-title":"Invasive aspergillosis caused by Aspergillus terreus: An emerging opportunistic infection with poor outcome independent of azole therapy","volume":"69","author":"Hachem","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jinf.2012.08.003","article-title":"Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry","volume":"65","author":"Steinbach","year":"2012","journal-title":"J. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/jac\/dks521","article-title":"High-dose induction liposomal amphotericin B followed by de-escalation is effective in experimental Aspergillus terreus pneumonia","volume":"68","author":"Lewis","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/377210","article-title":"Experimental pulmonary aspergillosis due to Aspergillus terreus: Pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B","volume":"188","author":"Walsh","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1128\/AAC.48.10.3715-3719.2004","article-title":"Antifungal therapy of murine Aspergillus terreus infections","volume":"48","author":"Graybill","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/AAC.01283-12","article-title":"New insights into amphotericin B resistance in Aspergillus terreus","volume":"57","author":"Blum","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"48","author":"Diekema","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: A multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2018, March 27). Antifungal Susceptibility Testing (AFST). Available online: http:\/\/www.eucast.org\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1128\/AAC.05164-14","article-title":"Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains","volume":"59","author":"Blatzer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1089\/ars.2014.6220","article-title":"Amphotericin B resistance in Aspergillus terreus is overpowered by coapplication of pro-oxidants","volume":"23","author":"Blatzer","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/mmy\/myx119","article-title":"Aspergillus terreus: Novel lessons learned on amphotericin B resistance","volume":"56","author":"Posch","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1128\/AAC.04204-14","article-title":"Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli","volume":"59","author":"Binder","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/21505594.2015.1045183","article-title":"Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance","volume":"6","author":"Maurer","year":"2015","journal-title":"Virulence"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00755-17","DOI":"10.1128\/AAC.00755-17","article-title":"Impact of morphological sectors on antifungal susceptibility testing and virulence studies","volume":"61","author":"Jukic","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.bmt.1704828","article-title":"Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients","volume":"35","author":"Trifilio","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/AAC.01436-12","article-title":"MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex","volume":"57","author":"Salas","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3389\/fmicb.2018.00516","article-title":"Azole-resistance in Aspergillus terreus and related species: An emerging problem or a rare phenomenon?","volume":"9","author":"Risslegger","year":"2018","journal-title":"Front. Micorbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/infdis\/jis442","article-title":"In vivo emergence of Aspergillus terreus with reduced azole susceptibility and a Cyp51a M217l alteration","volume":"206","author":"Arendrup","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jix210","article-title":"Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Chowdhary","year":"2017","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/3\/83\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:11:48Z","timestamp":1760195508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/4\/3\/83"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,9]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["jof4030083"],"URL":"https:\/\/doi.org\/10.3390\/jof4030083","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,9]]}}}